OR WAIT null SECS
Susan Haigney is lead editor of BioPharm International®.
August 03, 2020
The COVID-19 pandemic has raised several questions about the safety of the pharmaceutical materials supply chain. Is onshoring the answer?
Pharmaceutical Technology spoke with Matthew Woodcock, director of LLamasoft, a supply chain analytics company that assists companies in their decision-making and supply chain challenges, about the impact the COVID-19 pandemic has had on the pharmaceutical supply chain.
August 01, 2020
Hiring the right quality consultant can provide expertise and save costs.
September 01, 2019
Industry experts discuss the challenges and regulations of setting up a CGMP-compliant stability testing program.
April 02, 2017
The complex nature of biologics adds additional CQAs that must be determined to ensure the safe development of biologics